Download video

Adding Enzalutamide to Standard First-Line Treatment Improves Survival for Hormone-Sensitive Pro...

141 views

Oncoletter

5 years ago

Adding Enzalutamide to Standard First-Line Treatment Improves Survival for Hormone-Sensitive Pro...

Adding Enzalutamide to Standard First-Line Treatment Improves Survival for Hormone-Sensitive Pro...

Adding Enzalutamide to Standard First-Line Treatment Improves Survival for Hormone-Sensitive Pro...
11:48
Adding Enzalutamide to Standard First-Line Treatment Improves Survival for Hormone-Sensitive Pro...
by Oncoletter
ENZAMET trial: Early enzalutamide delays progression, improves survival in mHSPC
2:47
ENZAMET trial: Early enzalutamide delays progression, improves survival in mHSPC
by MDedge: news and insights for busy physicians
Current standards for first-line metastatic hormone-sensitive prostate cancer
2:10
Current standards for first-line metastatic hormone-sensitive prostate cancer
by VJOncology
Prostate Cancer: Research shows new treatment option offers improved survival
2:14
Prostate Cancer: Research shows new treatment option offers improved survival
by Dana-Farber Cancer Institute
Enzalutamide improves survival for men with metastatic hormone-sensitive prostate cancer
8:56
Enzalutamide improves survival for men with metastatic hormone-sensitive prostate cancer
by ecancer
First-line treatments for patients with mHSPC and mCRPC
2:34
First-line treatments for patients with mHSPC and mCRPC
by VJOncology
First-line treatments in metastatic prostate cancer
2:46
First-line treatments in metastatic prostate cancer
by VJOncology
Androgen Deprivation Therapy Plus Enzalutamide for Hormone-Sensitive Prostate Cancer
3:13
Androgen Deprivation Therapy Plus Enzalutamide for Hormone-Sensitive Prostate Cancer
by PracticeUpdate
ENZAMET trial
6:05
ENZAMET trial
by European Association of Urology
Addition of docetaxel to initial hormone therapy improves survival in prostate cancer
5:51
Addition of docetaxel to initial hormone therapy improves survival in prostate cancer
by ecancer
Enzalutamide + ADT in Men with De Novo mHSPC: The ARCHES Trial
5:11
Enzalutamide + ADT in Men with De Novo mHSPC: The ARCHES Trial
by Grand Rounds in Urology
Enzalutamide as treatment for men with mHSPC who have received testosterone suppression
3:38
Enzalutamide as treatment for men with mHSPC who have received testosterone suppression
by ecancer
'Treatment landscape for metastatic hormone-sensitive prostate cancer' - Dr Laeeq Malik Grand Rounds
44:49
'Treatment landscape for metastatic hormone-sensitive prostate cancer' - Dr Laeeq Malik Grand Rounds
by ANU School of Medicine and Psychology
Updated overall survival outcomes in ENZAMET (ANZUP 1304)
6:40
Updated overall survival outcomes in ENZAMET (ANZUP 1304)
by European Association of Urology
ARCHES trial overview: ADT plus enzalutamide for metastatic hormone-sensitive prostate cancer
1:55
ARCHES trial overview: ADT plus enzalutamide for metastatic hormone-sensitive prostate cancer
by VJOncology
STREAM trial: enzalutamide and androgen deprivation therapy with salvage radiation in men with h...
1:46
STREAM trial: enzalutamide and androgen deprivation therapy with salvage radiation in men with h...
by ecancer
Enzalutamide plus androgen deprivation therapy prolongs survival in men with metastatic hormone-...
6:06
Enzalutamide plus androgen deprivation therapy prolongs survival in men with metastatic hormone-...
by ecancer
Update on the ARCHES Trial: New Indication for Enzalutamide in mHSPC
6:02
Update on the ARCHES Trial: New Indication for Enzalutamide in mHSPC
by Grand Rounds in Urology
Dr. Sweeney on the Phase III ENZAMET Trial in Metastatic Hormone-Sensitive Prostate Cancer
2:46
Dr. Sweeney on the Phase III ENZAMET Trial in Metastatic Hormone-Sensitive Prostate Cancer
by OncLive
Developments in metastatic hormone-sensitive prostate cancer
25:53
Developments in metastatic hormone-sensitive prostate cancer
by ecancer